Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.

Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.

Item
http://www.wikidata.org/entity/Q37344807
Molecular studies of exercise, skeletal muscle, and ageingInhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondThe role of the ribosome in the regulation of longevity and lifespan extensionNaturally occurring p16(Ink4a)-positive cells shorten healthy lifespanAlcohol impairs skeletal muscle protein synthesis and mTOR signaling in a time-dependent manner following electrically stimulated muscle contractionReducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.Reduced in vivo hepatic proteome replacement rates but not cell proliferation rates predict maximum lifespan extension in mice.Reduced insulin/insulin-like growth factor signaling decreases translation in Drosophila and mice.The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise.Aging is not programmed: genetic pseudo-program is a shadow of developmental growth.Key proteins and pathways that regulate lifespan.Intact neuronal function in Rheb1 mutant mice: implications for TORC1-based treatments.Transcriptional programming of lipid and amino acid metabolism by the skeletal muscle circadian clock
P2860

Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.

Item
http://www.wikidata.org/entity/Q37344807
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@en
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@nl
type
label
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@en
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@nl
prefLabel
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@en
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932